Swedegene is currently collecting the following adverse drug reactions. More adverse drug reactions will be added to the initial list as the project proceeds and may involve any type.
- Angioedema related to ACE-inhibitors/ARBs.
- Cough related to ACE-inhibitors.
- Osteonecrosis and atypical fractures due to bisphosphonates.
- Phototoxic reactions due to topical NSAIDS and fluoroquinolones.
- Hypersensitivity, mainly to antibiotics and NSAIDs.
- Metabolic reactions from neuroleptics and antidepressants.
- Hyponatremia/SIADH due to antidepressants and antiepileptics.
- CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics.
- Stevens-Johnson syndrome/Toxic epidermal necrolysis.
- Mefloquine-induced psychiatric reactions.
- Tendon-rupture from flouroquinolones.
- Liver toxicity.
- Torsade de Pointes/QT-prolongation.
- Agranulocytosis.
- Rhabdomyolysis and myopahty due to lipid-lowering drugs.
- Rhabdomyolysis related to statins/fibrates.
- Narcolepsy associated with Pandemrix.
- Hearing impairment from aminoglycosides.
- Pancreatitis.
- Thrombocytopenia.
- Renal toxicity.
- Hair loss (alopecia).
- Bleeding due to new oral anticoagulants (NOAC).